Log In | Shopping Cart | Advanced Search
            
  • Home
  • Career
  • Distributors
  • Contact Us:
  • Email: crm@excellgen.com
Products
Modified mRNA
Encapsulated mRNA
mRNA Enzyme
SARS-CoV-2
Pseudovirus
Popular Products
Cancer Proteins
Antibodies
DNA Binding Proteins
Electrophoresis
Genome Engineering
Polymerases
Recombinases
Transcription Factors
Transfection
Comsumbles
Services
Modified mRNA
Custom Cloning
Virus Production
Protein Purification
Protein Expression
SARS-CoV-2
 Previous 
 Return to List 
 Next 

Murine Leukemia Virus (MLV) Pseudotyped with SARS-CoV-2 Spike Glycoprotein

Catalog #: EG-345


Qty:

Product Name Murine Leukemia Virus (MLV)Pseudotyped with SARS-CoV-2 Spike Glycoprotein, HexaPro Stabilized Trimer
Description Murine leukemia retrovirus (MLV) particles pseudotyped with SARS‑CoV‑2 spike glycoprotein, with hexaPro mutations so the surface protein antigenically optimal pre-fusion conformation, produced and purified from HEK 293 cells
Mutations Furin site RRAR mutated to GSAS; HexaPro mutations (K986P, V987P, F817P, A892P, A899P and A942P) to ensure the S glycoprotein remains in an antigenically optimal pre-fusion conformation
Source HEK293T cells
Reporter EGFP
Application
  • Screening of SARS‑CoV‑2 neutralizing antibodies
  • Assessment of vaccine efficacy
Titer > 1 X 107 RFU/ml or > 1 X 105 TU/ml
Shipping Dry ice
Storage -80 oC
References
    1. Murine Leukemia Virus (MLV)-based Coronavirus Spike-pseudotyped Particle Production and Infection. Bio Protoc. 2016 Dec 5; 6(23): e2035. doi:10.21769/BioProtoc.2035
    2. Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein doi: 10.1128/JVI.78.17.9007-9015.2004. PubMed: 15308697

     
 Ask a Question 
 
 Home | Privacy Policy | Terms & Conditions | Online Price Policy | Shipping & Return

Copyright © 2007-2023  Excellgen, Inc. All rights reserved